<SEC-DOCUMENT>0001193125-19-002336.txt : 20190104
<SEC-HEADER>0001193125-19-002336.hdr.sgml : 20190104
<ACCEPTANCE-DATETIME>20190104142734
ACCESSION NUMBER:		0001193125-19-002336
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20190103
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20190104
DATE AS OF CHANGE:		20190104

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			AMERICAN VANGUARD CORP
		CENTRAL INDEX KEY:			0000005981
		STANDARD INDUSTRIAL CLASSIFICATION:	AGRICULTURE CHEMICALS [2870]
		IRS NUMBER:				952588080
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-13795
		FILM NUMBER:		19509450

	BUSINESS ADDRESS:	
		STREET 1:		4695 MACARTHUR COURT
		CITY:			NEWPORT BEACH
		STATE:			CA
		ZIP:			92660
		BUSINESS PHONE:		949-260-1200

	MAIL ADDRESS:	
		STREET 1:		4695 MACARTHUR COURT
		CITY:			NEWPORT BEACH
		STATE:			CA
		ZIP:			92660

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	AEROCON INC
		DATE OF NAME CHANGE:	19720620
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d679979d8k.htm
<DESCRIPTION>8-K
<TEXT>
<HTML><HEAD>
<TITLE>8-K</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>UNITED STATES </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>SECURITIES AND EXCHANGE COMMISSION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Washington, D.C. 20549 </B></P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>FORM <FONT
STYLE="white-space:nowrap">8-K</FONT> </B></P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>CURRENT
REPORT </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>PURSUANT TO SECTION 13 OR 15(d) OF </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>THE SECURITIES EXCHANGE ACT OF 1934 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Date of Report (date of earliest event reported): January&nbsp;3, 2019 </B></P>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman" ALIGN="center"><B>AMERICAN VANGUARD CORPORATION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Exact name of registrant as specified in its charter) </B></P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD WIDTH="34%"></TD>
<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"><B>Delaware</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B><FONT STYLE="white-space:nowrap">001-13795</FONT></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B><FONT STYLE="white-space:nowrap">95-2588080</FONT></B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(State or other jurisdiction</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>of incorporation)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>Commission File Number</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(I.R.S. Employer</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Identification No.)</B></P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>4695 MacArthur Court </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Newport Beach, California 92660 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Address of principal executive offices) </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Registrant&#146;s telephone number: (949) <FONT STYLE="white-space:nowrap">260-1200</FONT> </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below if the Form <FONT STYLE="white-space:nowrap">8-K</FONT> filing is intended to simultaneously satisfy the filing obligation of
the registrant under any of the following provisions: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Soliciting material pursuant to Rule <FONT STYLE="white-space:nowrap">14a-12</FONT> under the Exchange Act (17
CFR <FONT STYLE="white-space:nowrap">240.14a-12)</FONT> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><FONT STYLE="white-space:nowrap">Pre-commencement</FONT> communications pursuant to Rule <FONT
STYLE="white-space:nowrap">14d-2(b)</FONT> under the Exchange Act (17 CFR <FONT STYLE="white-space:nowrap">240.14d-2(b))</FONT> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><FONT STYLE="white-space:nowrap">Pre-commencement</FONT> communications pursuant to Rule <FONT
STYLE="white-space:nowrap">13e-4(c)</FONT> under the Exchange Act (17 CFR <FONT STYLE="white-space:nowrap">240.13e-4(c))</FONT> </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this
chapter) or Rule 12b02 of the Securities Exchange Act of 1934 (&#167;240.12b02 of this chapter). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B></B>Emerging Growth
Company&nbsp;&nbsp;&#9744; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period
for complying with any new or revised financial accounting standards provided pursuant to Section&nbsp;13(a) of the Exchange Act.&nbsp;&nbsp;&#9744; </P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%" VALIGN="top" ALIGN="left"><B>Item&nbsp;8.01</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Other Events </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On January&nbsp;3, 2019, American Vanguard Corporation issued a press release announcing that it had completed the acquisition of the quizalofop product line
of herbicides from Corteva AgriScience, Agriculture Division of DowDupont (&#147;Corteva&#148;). That release is linked hereto as Exhibit 99.1 and is incorporated by reference herein in its entirety. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The information contained in this Current Report on Form <FONT STYLE="white-space:nowrap">8-K,</FONT> including the Exhibit linked hereto, is being furnished
under Items 8.01 and 9.01 and shall not be deemed &#147;filed&#148; for purposes of Section&nbsp;18 of the Securities Exchange Act of 1934, as amended (the &#147;Exchange Act&#148;), or incorporated by reference in any filing under the Securities
Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%" VALIGN="top" ALIGN="left"><B>Item&nbsp;9.01</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Financial Statements and Exhibits. </B></P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(d) Exhibits </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="88%"></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>Exhibit&nbsp;99.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d679979dex991.htm">Press release dated January&nbsp;3, 2019 of American Vanguard Corporation announcing the completion of a product line acquisition from Corteva.</A></TD></TR>
</TABLE>
</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SIGNATURES </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, American Vanguard Corporation has duly caused this report to be signed on
its behalf by the undersigned, thereunto duly authorized. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="45%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom"></TD>
<TD WIDTH="44%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">AMERICAN VANGUARD CORPORATION</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date: January&nbsp;4, 2019</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">/s/ Timothy J. Donnelly</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Timothy J. Donnelly</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Chief Administrative Officer, General Counsel</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&amp; Secretary</TD></TR>
</TABLE>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>d679979dex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.1 </B></P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g679979g99f41.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>FOR IMMEDIATE RELEASE </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>AMERICAN VANGUARD ACQUIRES HERBICIDE PRODUCT LINE FROM CORTEVA AGRISCIENCE&#153; </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B><I>Acquired products are complementary to major herbicide tolerant crop systems </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">Newport Beach, CA &#150; January&nbsp;3, 2019 &#150; American Vanguard Corporation (NYSE:AVD), today announced the acquisition of the Quizalofop (QPE) product
line of herbicides from Corteva Agriscience, Agriculture Division of DowDuPont (NYSE: DWDP). The primary markets for these products are in Canola, Soybeans and Pulse in the United States and Canada. This transaction includes acquisition of technical
registrations, commercial sales information, and the transfer of existing product supply arrangements. Financial terms are not being disclosed. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">Eric
Wintemute, Chairman and CEO of American Vanguard commented, &#147;Our acquisition of the QPE product line from Corteva Agriscience provides our crop protection business with a portfolio of valuable herbicide brands that hold significant leadership
positions in the North American market. These products are complementary to existing glyphosate, glufosinate and 2,4D use, and are highly regarded for weed and grass control by providing a broad window of application and excellent crop safety.&#148;
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">Mr.&nbsp;Wintemute continued, &#147;Additionally, the new DowDuPont Enlist&#153; seed trait technology for corn provides crop tolerance to these QPE
herbicides, making them ideal for achieving improved weed management. In this acquisition, AVD has secured a license to market QPE for use alone or with Enlist herbicides
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">over-the-top</FONT></FONT> of the new Enlist corn seeds, a segment that is forecast to grow considerably in coming years.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">Mr.&nbsp;Wintemute concluded, &#147;These products have a well-established market position, are solidly profitable and offer the promise of growth as the
Enlist trait technology expands. In this transaction, we also acquired the rights to market in Argentina and Chile which dovetails with our initiative to increase market access in that South American region. We will continue multiple existing supply
agreements for these products and incorporate the sales&nbsp;&amp; marketing of these brands into our expanding portfolio of herbicide offerings.&#148; </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About American Vanguard </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">American Vanguard Corporation is
a diversified specialty and agricultural products company that develops and markets products for crop protection and management, turf and ornamentals management and public and animal health. American Vanguard is included on the Russell 2000<SUP
STYLE="font-size:85%; vertical-align:top">&reg;</SUP> and Russell 3000<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP> Indexes and the Standard&nbsp;&amp; Poor&#146;s Small Cap 600 Index. To learn more about American Vanguard, please
reference the Company&#146;s web site at <U>www.american-vanguard.com</U>. </P>
</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company, from time to time, may discuss forward-looking information. Except for the historical
information contained in this release, all forward-looking statements are estimates by the Company&#146;s management and are subject to various risks and uncertainties that may cause results to differ from management&#146;s current expectations.
Such factors include weather conditions, changes in regulatory policy and other risks as detailed from <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">time-to-time</FONT></FONT> in the Company&#146;s SEC reports and filings. All
forward-looking statements, if any, in this release represent the Company&#146;s judgment as of the date of this release. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="51%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="47%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"><B>Company Contact:</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>Investor Representative</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">American Vanguard Corporation</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">The Equity Group Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">William A. Kuser, Director of Investor Relations</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">www.theequitygroup.com</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">(949) <FONT STYLE="white-space:nowrap">260-1200</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Lena Cati (212) <FONT STYLE="white-space:nowrap">836-9611</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">williamk@amvac-chemical.com</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Lcati@equityny.com</TD></TR>
</TABLE>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g679979g99f41.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g679979g99f41.jpg
M_]C_X  02D9)1@ !  $!0 %   #__@ ?3$5!1"!496-H;F]L;V=I97,@26YC
M+B!6,2XP,0#_VP"$  @&!@<&!0@'!P<*"0@*#18.#0P,#1L3%! 6(!PB(1\<
M'QXC*#,K(R8P)AX?+#TM,#4V.3HY(BL_0SXX0S,X.3<!"0H*#0L-&@X.&C<D
M'R0W-S<W-S<W-S<W-S<W-S<W-S<W-S<W-S<W-S<W-S<W-S<W-S<W-S<W-S<W
M-S<W-S<W-__$ :(   $% 0$! 0$!           ! @,$!08'" D*"P$  P$!
M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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MG [U,\HQ,(N3MIYFOUB)Z'FO*.@6@ H * "@ H * "@ H * "@ H * "@ H
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MPNL+I<GE3EU&5R7!('Y8H KWGQ*O(]$6[MK"V-RU[<6RQN\C96+N%1&8D_3
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.. !0 4 % !0 4 % '_]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
